NDC 62207-321

IBUPROFEN

Ibuprofen

IBUPROFEN is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Granules India Limited. The primary component is Ibuprofen.

Product ID62207-321_9a5c4500-0113-0257-e053-2995a90a2409
NDC62207-321
Product TypeHuman Otc Drug
Proprietary NameIBUPROFEN
Generic NameIbuprofen
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-11-14
Marketing CategoryANDA / ANDA
Application NumberANDA202312
Labeler NameGranules India Limited
Substance NameIBUPROFEN
Active Ingredient Strength200 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 62207-321-41

24 TABLET in 1 BOTTLE (62207-321-41)
Marketing Start Date2019-11-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62207-321-42 [62207032142]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-91 [62207032191]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-49 [62207032149]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-43 [62207032143]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-47 [62207032147]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-41 [62207032141]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-48 [62207032148]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

NDC 62207-321-46 [62207032146]

IBUPROFEN TABLET
Marketing CategoryANDA
Application NumberANDA202312
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-11-14

Drug Details

Active Ingredients

IngredientStrength
IBUPROFEN200 mg/1

OpenFDA Data

SPL SET ID:97516b9f-219a-429d-850d-1fe9fd66646b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310965
  • UPC Code
  • 0362207321495
  • 0362207321433
  • 0362207321471
  • 0362207321464
  • NDC Crossover Matching brand name "IBUPROFEN" or generic name "Ibuprofen"

    NDCBrand NameGeneric Name
    67877-120ibuprofenibuprofen
    67877-119ibuprofenibuprofen
    67877-295ibuprofenibuprofen
    67877-121ibuprofenibuprofen
    67877-294ibuprofenibuprofen
    67877-296ibuprofenibuprofen
    67877-321IbuprofenIbuprofen
    67877-319IbuprofenIbuprofen
    67877-320IbuprofenIbuprofen
    68016-116IbuprofenIbuprofen
    68016-633IbuprofenIbuprofen
    68016-626IbuprofenIbuprofen
    68016-634IbuprofenIbuprofen
    68016-645IbuprofenIbuprofen
    68016-295IbuprofenIbuprofen
    68016-635IbuprofenIbuprofen
    68071-3074IbuprofenIbuprofen
    68071-3362IBUPROFENIBUPROFEN
    68071-4129IbuprofenIbuprofen
    68071-4009IBUPROFENIBUPROFEN
    68071-3388IbuprofenIbuprofen
    68071-4253IbuprofenIbuprofen
    68071-4306IbuprofenIbuprofen
    68071-4357IbuprofenIbuprofen
    68071-4563IbuprofenIbuprofen
    68071-4280IbuprofenIbuprofen
    68071-4243IBUPROFENIBUPROFEN
    68071-4820IbuprofenIbuprofen
    68071-4305IbuprofenIbuprofen
    68071-4459IBUPROFENIBUPROFEN
    68084-703IbuprofenIbuprofen
    68084-658IbuprofenIbuprofen
    68084-772IbuprofenIbuprofen
    68196-980IbuprofenIbuprofen
    68196-981IbuprofenIbuprofen
    68210-0200IBUPROFENIBUPROFEN
    68196-199IbuprofenIbuprofen
    68210-0009IBUPROFENIBUPROFEN
    68196-745IbuprofenIbuprofen
    68387-208IbuprofenIbuprofen
    0472-2002IbuprofenIbuprofen
    68387-210IbuprofenIbuprofen
    68391-121IbuprofenIbuprofen
    68391-199IbuprofenIbuprofen
    0472-1270IbuprofenIbuprofen
    68645-531IbuprofenIbuprofen
    68645-563IbuprofenIbuprofen
    68645-562IbuprofenIbuprofen
    68645-561IbuprofenIbuprofen
    0113-1461basic care childrens ibuprofenIbuprofen

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.